Scientific accuracy
Each model is designed with our pioneering customers using a usage-oriented methodology, and then the products are validated by independent studies before being launched on the market.
Our Story
In 2026, Exosafe will take over Rb3D's assets and expertise to market three extraordinary products resulting from several years of development. These products are perfectly suited to a rapidly expanding market. A common observation: we don't have the right to let the body pay for what the organization cannot change.
Our Mission
87% of recognized occupational diseases are musculoskeletal disorders. Behind this figure lie millions of days of absence, broken careers, and disrupted families.
Our conviction: the exoskeleton is not a gadget. When well-chosen, well-integrated, and well-monitored, it is an effective, measurable, and human response to the challenge of prevention.
Discover our models+1000
equipped operators
Our Values
Each model is designed with our pioneering customers using a usage-oriented methodology, and then the products are validated by independent studies before being launched on the market.
Parts made in France, recyclable materials, short supply chain, and local after-sales service.
We are always listening to you so that we can constantly improve our products to better meet your uses and needs. We don't deliver a package, we support a change.
The team
CEO (Chief Executive Officer)
COO (Chief Operating Officer) / R&D
HPO (Human Performance Officer)
CFO (Chief Financial Officer)
Our journey
2021
Leveraging all its experience in active exoskeletons, Rb3D releases its first passive prototype, the EXOVITI.
2022
The EXOVITI leaves the workshops and receives CE certification.
2023 - 2024
The SYMBO is an even more discreet and lighter exoskeleton to further improve its acceptability
2025
2026
Launch of the new EXO UP product for overhead work
We're recruiting people passionate about ergonomics, mechatronics, and tangible impact.
Submit your resume